Knowledge Base
This section provides concise context for frequently used oncology terms; it is not a substitute for clinical judgment.
ECOG
Performance status scale used as context in treatment tolerance and trial evaluation.
HER2
Biomarker axis that can influence targeted treatment pathways in selected tumors.
Ki-67
Cell proliferation indicator used as a supportive parameter in tumor biology interpretation.
Clinical trial eligibility
Requires protocol criteria, listing context, and site-level review together.
Tumor board
Multidisciplinary structure where teams prepare shared decisions on a case.
Biomarker context
Not a single lab value, but a signal interpreted within the full clinical picture.